COVID-19 Vaccines

Children under 5 years old are the last remaining group of people who are not yet eligible for COVID-19 bivalent vaccines.

Early demand for the new COVID-19 bivalent booster vaccines is off to a slow start. Health providers and residents say It could be the new normal.

New COVID-19 booster vaccines are making their debut this fall, and they’ll be available to most adults.

The hope is that the modified boosters will blunt yet another winter surge.

Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August, according to the American Academy of Pediatrics.

The Maryland-based company hopes the U.S. also clears booster doses and teen use fairly soon.

The Centers for Disease Control still must recommend how to use the Novavax vaccine before shots begin. The U.S. has bought 3.2 million doses.

The warning comes as two new highly transmissible variants are spreading rapidly across the country.

Some Philadelphia parents who are eager to vaccinate their infants and toddlers must be patient a little while longer.

Philly officials are trying to spread the word that city health centers have the COVID-19 vaccine available for children under 5.

Advisers to the U.S. government are recommending that COVID-19 booster shots used this fall be modified to better match more recent variants of the coronavirus.

Saturday's announcement comes just days before regulators debate whether to offer Americans updated booster shots this fall.

The nation’s infants, toddlers and preschoolers are finally getting their chance at COVID-19 vaccination as the U.S. rolls out shots for tots this week.

U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.

U.S. regulators have authorized the first COVID-19 shots for infants and preschoolers. That paves the way for vaccinations for children under 5 to begin next week.